Simvita (RUBIMED AG)


Welcome to the PulseAid listing for the Simvita drug offered from RUBIMED AG. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: RUBIMED AG
NON-PROPRIETARY NAME: Claviceps Purpurea Sclerotium, Sus Scrofa Cerebellum, Epinephrine, and Tuberculin Purified Protein Derivative
SUBSTANCE NAME: CLAVICEPS PURPUREA SCLEROTIUM; SUS SCROFA CEREBELLUM; EPINEPHRINE; TUBERCULIN PURIFIED PROTEIN DERIVATIVE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-05-07
END MARKETING DATE: 0000-00-00


Simvita HUMAN OTC DRUG Details:

Item DescriptionSimvita from RUBIMED AG
LABELER NAME: RUBIMED AG
DEA SCHEDULE:
ACTIVE STRENGTH: 12; 21; 30; 200([hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL)
START MARKETING DATE: 2015-05-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66343-005_24170b2d-a369-49f1-a161-52725f70d210
PRODUCT NDC: 66343-005
APPLICATION NUMBER:

Other CLAVICEPS PURPUREA SCLEROTIUM; SUS SCROFA CEREBELLUM; EPINEPHRINE; TUBERCULIN PURIFIED PROTEIN DERIVATIVE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
RUBIMED AGSimvita